Favorable Conditions for the Detection of EGFR T790M Mutation Using Plasma Sample in Patients with Non-Small-Cell Lung Cancer

SIMPLE SUMMARY: Up to 60% of patients with non-small-cell lung cancer with epidermal growth factor receptor (EGFR) acquire a T790M mutation after first-line EGFR-tyrosine kinase inhibitors (TKIs). Although a liquid biopsy using plasma samples for the detection of the T790M mutation is recommended in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Insu, Seol, Hee Yun, Kim, Soo Han, Kim, Mi-Hyun, Lee, Min Ki, Eom, Jung Seop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000691/
https://www.ncbi.nlm.nih.gov/pubmed/36900237
http://dx.doi.org/10.3390/cancers15051445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000691/
https://www.ncbi.nlm.nih.gov/pubmed/36900237
http://dx.doi.org/10.3390/cancers15051445

Ejemplares similares